COVACIMMUNE Trademark

Trademark Overview

On Thursday, December 24, 2020, a trademark application was filed for COVACIMMUNE with the United States Patent and Trademark Office. The USPTO has given the COVACIMMUNE trademark a serial number of 90410480. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 5, 2024. This trademark is owned by AFFIMEDIX, INC.. The COVACIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease and immunity detection, namely, coronavirus disease
covacimmune

General Information

Serial Number90410480
Word MarkCOVACIMMUNE
Filing DateThursday, December 24, 2020
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2024

Trademark Statements

Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease and immunity detection, namely, coronavirus disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAFFIMEDIX, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NameAFFIMEDIX, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events

Event DateEvent Description
Tuesday, December 29, 2020NEW APPLICATION ENTERED
Friday, March 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 25, 2021ASSIGNED TO EXAMINER
Wednesday, June 2, 2021SUSPENSION LETTER WRITTEN
Wednesday, June 2, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, June 2, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 6, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, January 5, 2022ASSIGNED TO EXAMINER
Monday, January 10, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, January 16, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, April 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 5, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 19, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Monday, March 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 19, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 13, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 25, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 7, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, August 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, February 10, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

covacimmune disease diagnostic immunity detection coronavirus namely fluids testing comprised kits